Page last updated: 2024-08-17

1,2,3,4-tetrahydroisoquinoline and Neoplasms

1,2,3,4-tetrahydroisoquinoline has been researched along with Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Bartolucci, G; Braconi, L; Chiaramonte, N; Colabufo, NA; Contino, M; Dei, S; Giampietro, R; Manetti, D; Perrone, MG; Riganti, C; Romanelli, MN; Teodori, E1
Cheng, K; Fang, Y; Hua, H; Ji, B; Li, D; Li, H; Li, Z; Wu, B; Zheng, C1
Shah, P; Singh, IP1

Reviews

2 review(s) available for 1,2,3,4-tetrahydroisoquinoline and Neoplasms

ArticleYear
Renieramycin-type alkaloids from marine-derived organisms: Synthetic chemistry, biological activity and structural modification.
    European journal of medicinal chemistry, 2021, Jan-15, Volume: 210

    Topics: Alkaloids; Anti-Infective Agents; Antibiotics, Antineoplastic; Antiprotozoal Agents; Biological Products; Molecular Structure; Neoplasms; Tetrahydroisoquinolines

2021
Tetrahydroisoquinolines in therapeutics: a patent review (2010-2015).
    Expert opinion on therapeutic patents, 2017, Volume: 27, Issue:1

    Topics: Animals; Antineoplastic Agents, Alkylating; Central Nervous System Diseases; Dioxoles; Drug Design; Humans; Neoplasms; Patents as Topic; Tetrahydroisoquinolines; Trabectedin

2017

Other Studies

1 other study(ies) available for 1,2,3,4-tetrahydroisoquinoline and Neoplasms

ArticleYear
6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline amides and corresponding ester isosteres as multidrug resistance reversers.
    Journal of enzyme inhibition and medicinal chemistry, 2020, Volume: 35, Issue:1

    Topics: Amides; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Dogs; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Esters; Humans; Molecular Structure; Neoplasms; Structure-Activity Relationship; Tetrahydroisoquinolines

2020